🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Amicus Therapeutics Inc (FOLD)

NASDAQ
Currency in USD
Disclaimer
9.660
+0.190(+2.01%)
Closed
After Hours
9.6600.000(0.00%)

FOLD Comments

Trading idea - Entry point has to be over 12/61.80%
I wish i could be the CEO of the company. He sold his stocks accidentally on friday.
I also sold at 8.8 after almost 2 years of bagholding. Now it's up
now breakout
04.11 = MA 50 crossed above the MA200
monthly return= -25%
Been spendin' most their livesLivin' in a shorters's paradise(4x)
For 2021, the company expects total Galafold revenues of at least $300-$315 million, driven by continued operational growth and commercial execution across all major markets, including the United States, the EU, the U.K. and Japan.
buying, crashing in 2 days, bagholding for a year to breakeven, crashing in 2 days, repeat
with WH already worked, waiting here
just sent to WSB the offer to try short squuze with WH and FOLD, let's see
hahaah tnx
why is it going down today?
Avoid any recommendations (it's monkey business for big) use your brain and intuition, then you save your own money.
O co chodzi, Wojciech?
 I've been investing for more then four years from now. So, I followed, at the begining, recommendations given by so called experts. More then 60% of its were wrong or disapointed me. Now I know that my estimation of stock and intuition is no worse and some times better then experts from banks, etc. I try to follow Buffet's point of view in investing, of course, reading all opinions and recommendations given.
I was right: *****and see you next year!
Going south, 7, 5 or very bottom $2? Amicus=amicable or .... reverse.
FOLD price target raised to $30
Where are you finding this information?
TipRanks says $20-24 which seems more realistic.
A great news! . It was announced today that Amicus Therapeutics Launches Galafold(TM) (Migalastat) for Treatment of Fabry Disease in Italy!. .
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.